论文部分内容阅读
一、项目名称:抗病毒性肝炎新药蕨麻素(JMS) 二、招商主体:解放军第三○二医院是全军乃至全国唯一一家以治疗肝病为主的大型传染病专科医院。近年来,医院注重抗肝炎新药的研究与开发。药物研究中心在职人员40余人。学科队伍中有正高职研究人员4人、副高职8人;具有博士学位4人、硕士学位10人;博士生导师2人,硕士生导师5人。近五年来,研究中心共获得国家科技进步三等奖2项,军队科技进步二等奖8项,军队科技进步三等奖10项,军队科技进步医疗成果奖2项;
I. Project Name New Anti-viral Hepatitis (JMS) II. Investment Attraction: The 302 Hospital of People’s Liberation Army is the only major infectious disease hospital specialized in the treatment of liver disease in the whole army and even in the whole country. In recent years, the hospital focuses on the research and development of new anti-hepatitis drugs. Drug Research Center staff serving more than 40 people. Discipline team has four senior research staff, eight associate professors; with a doctorate 4, master’s degree 10; doctoral tutor 2, Master Instructor 5 people. In the past five years, the research center has won 2 third prize of national scientific and technological progress, 8 second prize of army’s scientific and technological progress, 10 third prize of army’s scientific and technological progress, and 2 medical progress awards of military science and technology.